Blood Reagent Buyers Put J&J, Immucor In Hot Seat

Law360, New York (June 1, 2009, 12:00 AM EDT) -- Hospitals, blood banks and clinical laboratories accusing Immucor Inc. and a Johnson & Johnson subsidiary of fixing the price for widely used blood reagents have asked the court to consolidate the seven direct purchaser antitrust class actions facing the defendants.

On Friday, Warren General Hospital urged Judge Susan D. Wigenton of the U.S. District Court for the District of New Jersey to unite the direct purchaser allegations that Immucor and Ortho-Clinical Diagnostics Inc. conspired to hike the prices for their blood reagent products, which are used...
To view the full article, register now.